Last week, the Centers for Disease Control and Prevention issued a warning against holiday travel. The day after 1 million Americans got on a plane, it’s the highest volume of travelers airports have seen since the pandemic.
Plus, how the country’s largest public university system is handling Thanksgiving.
And, the life and death implications of delaying the presidential transition.
Guests: Axios’ Joann Muller, and Russell Contreras and State University of New York Chancellor Jim Malatras.
U.S. COVID-19 cases cross 11 million as pandemic intensifies, 4 astronauts make history as SpaceX’s ‘Resilience’ launches for International Space Station, and Pennsylvania group delivers thousands of cookies to frontline workers during pandemic.
Anthony S. Fauci, MD returns to JAMA’s Q&A series to discuss the latest developments in the COVID-19 pandemic, including the continued importance of nonpharmaceutical interventions (masking, handwashing, physical distancing) for managing rising case numbers in the US and globally.
Recorded October 28, 2020.
Topics discussed in this interview: 0:00 Introduction 0:20 NAM Presidential Citation for Exemplary Leadership 1:19 COVID-19 numbers and excess deaths 4:05 National masking mandate 5:55 How to get people to accept masking 7:07 Herd Immunity and the Great Barrington Declaration 9:51 The holidays and airplane travel 13:44 Therapies update 17:54 Vaccines update 20:08 Vaccine distribution 22:00 Vaccine safety 24:42 How Australia has dealt with COVID-19 spikes 27:00 Acknowledgements and baseball
The structure of a beetle’s super-strong exoskeleton could open up new engineering applications, and efforts to address diversity and equality imbalances in academia.
In this episode:
01:17 Insights into an armoured insect
The diabolical ironclad beetle has an exoskeleton so strong, it can survive being run over by a car. Researchers have identified how the structure of the exoskeleton provides this strength, and show that mimicking it may lead to improved aerospace components.
This week, the UK government announced plans to run a ‘human challenge trial’, where healthy volunteers are deliberately infected with the SARS-CoV-2 virus. We talk about the process, the ethical and procedural hurdles, and whether such an approach will provide any useful data.
Staff Writer Robert Service talks with host Sarah Crespi about a different approach to COVID-19 testing that might be useful in response to the high numbers of cases in the United States. To break chains of transmission and community spread, the new strategy would replace highly accurate but slow polymerase chain reaction (PCR) tests with cheaper, faster tests that are less accurate but can be administered frequently.
Such tests cost between $1 and $3 compared with more than $100 for diagnostic PCR tests and give results in less than 30 minutes instead of days. Read all of our coronavirus coverage here. Also this week, Salma Mousa, a postdoctoral fellow at Stanford University, joins Sarah to talk about an experiment that added Muslim players to teams in a Christian soccer league in northern Iraq. The goal of the study was to see whether this type of social contact would change how the Christians—a threatened minority in the region—behaved toward Muslims, on and off the field.